A study of human neuroblastoma cells demonstrated that estrogen treatment increased MMP-9-mediated degradation of Aβ, suggesting that the regulatory role of estrogen in MMP-9 activity may constitute a neuroprotective mechanism against the pathological progression of AD [33]. This evidence concerns the gene MMP9 and Alzheimer disease.